PMID: 1206738Nov 1, 1975Paper

Cell-mediated immune responses to transplanted tumors in mice chronically exposed to cigarette smoke

Journal of the National Cancer Institute
J ChalmerD Keast

Abstract

C57BL and BALB/c mice were exposed to fresh cigarette smoke for 7-8 minutes per day for varying periods up to 30 weeks before subcutaneous or intratracheal inoculation of viable tumor cells. The growth rates of subcutaneous tumors in the mice exposed to smoke were significantly higher than those of controls and more lung metastases were noted. Enhanced tumor growth rates in the respiratory tracts of smoke-exposed mice were evidenced by the markedly increased death rates in these animals after the intratracheal inoculation of tumor cells. Increased tumor growth rates in mice that inhaled smoke were assoicated with depressed tumor-specific cytotoxic responses in both spleens and regional lymph nodes. Short-term exposure (10 wk) of mice to cigarette smoke resulted in decreased tumor growth rates concomitant with enhanced cytotoxic responses.

Citations

Jan 1, 1985·Journal of Surgical Oncology·A RichtersW P Alley
Jul 1, 1981·Archives of Environmental Health·D Keast, D J Ayre
Oct 7, 2005·Toxicological Sciences : an Official Journal of the Society of Toxicology·Sheung P NgJudith T Zelikoff
Oct 1, 1992·American Journal of Public Health·D ScholesA S Stergachis
Oct 1, 1983·Environmental Health Perspectives·A Richters, K Kuraitis
Jan 21, 1993·The New England Journal of Medicine·G P BrowmanM N Levine
Jul 1, 1983·Journal of Toxicology and Environmental Health·C AranyiF J Miller
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T FujisawaH Ohwada
Mar 31, 2009·Nature Reviews. Immunology·Martin R Stämpfli, Gary P Anderson
Feb 29, 2008·Journal of Toxicology and Environmental Health. Part a·Sheung P Ng, Judith T Zelikoff
Jan 1, 1981·Journal of Surgical Oncology·A Richters
Oct 29, 1983·The Medical Journal of Australia·R C Burton
Jun 4, 1998·Journal of Neuroimmunology·M L Sopori, W Kozak
May 1, 1996·Journal of the American Academy of Dermatology·J B Smith, N A Fenske

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.